Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?
Abstract Objectives To assess whether persistence to treatment with methotrexate (MTX) in early rheumatoid arthritis (RA) is shared among first-degree relatives with RA and to estimate any underlying heritability. Methods First-degree relative pairs diagnosed with RA 1999–2018 and starting MTX (in m...
Main Authors: | Anton Öberg Sysojev, Thomas Frisell, Bénédicte Delcoigne, Saedis Saevarsdottir, Johan Askling, Helga Westerlind |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-022-02873-z |
Similar Items
-
Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study
by: Johan Askling, et al.
Published: (2023-10-01) -
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study
by: Johan Askling, et al.
Published: (2022-12-01) -
Methotrexate in Treatment of Rheumatoid Arthritis
by: Wiewiόrowski Maciej, et al.
Published: (1999-08-01) -
Methotrexate intolerance in Rheumatoid Arthritis
by: Harjit Singh Nalwa, et al.
Published: (2023-03-01) -
Relationship between methotrexate dose and clinical efficacy for treatment of rheumatoid arthritis
by: HE Longquan, et al.
Published: (2020-09-01)